Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.06 USD | +1.77% | -10.14% | +60.56% |
Financials (USD)
Sales 2024 * | 71.56M | Sales 2025 * | 277M | Capitalization | 5.46B |
---|---|---|---|---|---|
Net income 2024 * | -437M | Net income 2025 * | -307M | EV / Sales 2024 * | 76.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 19.7 x |
P/E ratio 2024 * |
-10.8
x | P/E ratio 2025 * |
-15.5
x | Employees | 628 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 20.69% |
Latest transcript on ImmunityBio, Inc.
1 day | +1.77% | ||
1 week | -10.14% | ||
Current month | +0.88% | ||
1 month | +30.84% | ||
3 months | +75.98% | ||
6 months | +183.30% | ||
Current year | +60.56% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
Founder | 71 | 14-11-30 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 14-11-30 | |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 19-05-31 |
Wesley Clark
BRD | Director/Board Member | 78 | 21-02-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 8.06 | +1.77% | 4,361,642 |
24-05-08 | 7.92 | -4.12% | 5,212,663 |
24-05-07 | 8.26 | +5.76% | 9,581,369 |
24-05-06 | 7.81 | -14.64% | 10,789,460 |
24-05-03 | 9.15 | +2.01% | 14,704,253 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.56% | 5.46B | |
+2.97% | 108B | |
+10.21% | 104B | |
+1.57% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- IBRX Stock